Ducommun (DCO) Stock Overview
Provides engineering and manufacturing services for products and applications used in the aerospace and defense, industrial, medical, and other industries in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for DCO from our risk checks.
DCO Community Fair Values
Create NarrativeSee what 18 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Ducommun Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$168.09 |
| 52 Week High | US$210.39 |
| 52 Week Low | US$84.76 |
| Beta | 1.04 |
| 1 Month Change | -12.29% |
| 3 Month Change | 3.59% |
| 1 Year Change | 78.40% |
| 3 Year Change | 287.66% |
| 5 Year Change | 224.12% |
| Change since IPO | 1,065.94% |
Recent News & Updates
Seeking Alpha • 2h
Ducommun: Why I See Upside Despite Aerospace Multiple Pressure
Summary Ducommun remains a Buy as Vision 2032 targets 7-8% organic growth, a 23% EBITDA margin, and a larger Engineered Products mix. DCO's investment case now leans on defense and proprietary products, with commercial aerospace recovery and missile/radar programs driving incremental demand. Valuation upside depends on EV/EBITDA multiple expansion toward peers; the new price target is $216.50, reflecting improved estimates but lower sector multiples. Acquisitions up to $500 million are possible, but larger deals introduce integration, dilution, and financing risks, especially if equity is required. Read the full article on Seeking Alpha
Narrative Update • Sep 05
DCO: Missiles Demand Will Drive Future Repricing Despite Legacy Defense Concerns
Analysts have raised their Ducommun price target from $150 to $200, citing updated aerospace and defense models, stronger profit margin assumptions, recent growth in the missiles business, and support from higher Street targets clustered between $175 and $228. Analyst Commentary on Ducommun Recent research on Ducommun reflects a mix of optimism about the missiles business and caution about how much of that story is already reflected in the current share price.
Narrative Update • Aug 22
DCO: Missile Upside And Aero Recovery Will Offset Valuation And Budget Headwinds
The analyst fair value estimate for Ducommun has been raised from $190.80 to $212.00 as analysts factor in higher Street price targets from Citi and Truist, supported by reported missiles growth and updated aerospace and defense models. Analyst Commentary Recent Street commentary on Ducommun gives you a mix of optimism around missiles exposure and commercial aerospace, with some caution on how much of that story is already reflected in the share price.
New Narrative • Aug 09
Missile Backlog And Engineered Products Will Reshape This Aerospace Supplier’s Long-Term Prospects
Catalysts About Ducommun Ducommun supplies engineered products and complex electronic and structural solutions to Commercial Aerospace, Military and Space customers. What are the underlying business or industry changes driving this perspective?Recent updates
Seeking Alpha • 2h
Ducommun: Why I See Upside Despite Aerospace Multiple Pressure
Summary Ducommun remains a Buy as Vision 2032 targets 7-8% organic growth, a 23% EBITDA margin, and a larger Engineered Products mix. DCO's investment case now leans on defense and proprietary products, with commercial aerospace recovery and missile/radar programs driving incremental demand. Valuation upside depends on EV/EBITDA multiple expansion toward peers; the new price target is $216.50, reflecting improved estimates but lower sector multiples. Acquisitions up to $500 million are possible, but larger deals introduce integration, dilution, and financing risks, especially if equity is required. Read the full article on Seeking AlphaNarrative Update • Sep 05
DCO: Missiles Demand Will Drive Future Repricing Despite Legacy Defense Concerns
Analysts have raised their Ducommun price target from $150 to $200, citing updated aerospace and defense models, stronger profit margin assumptions, recent growth in the missiles business, and support from higher Street targets clustered between $175 and $228. Analyst Commentary on Ducommun Recent research on Ducommun reflects a mix of optimism about the missiles business and caution about how much of that story is already reflected in the current share price.Narrative Update • Aug 22
DCO: Missile Upside And Aero Recovery Will Offset Valuation And Budget Headwinds
The analyst fair value estimate for Ducommun has been raised from $190.80 to $212.00 as analysts factor in higher Street price targets from Citi and Truist, supported by reported missiles growth and updated aerospace and defense models. Analyst Commentary Recent Street commentary on Ducommun gives you a mix of optimism around missiles exposure and commercial aerospace, with some caution on how much of that story is already reflected in the share price.New Narrative • Aug 09
Missile Backlog And Engineered Products Will Reshape This Aerospace Supplier’s Long-Term Prospects
Catalysts About Ducommun Ducommun supplies engineered products and complex electronic and structural solutions to Commercial Aerospace, Military and Space customers. What are the underlying business or industry changes driving this perspective?Narrative Update • Aug 07
DCO: Missile Upside And Aero Recovery Will Balance Defense Budget Pressure
Ducommun's analyst fair value estimate has been updated from $181 to $190.80 as analysts factor in higher profit margin assumptions, a slightly lower future P/E multiple, and ongoing discussion around missile and munitions exposure versus potential budget pressure on legacy defense programs. Analyst Commentary Recent Street research on Ducommun gives you a mixed picture that focuses on execution in missiles and munitions, exposure to commercial aerospace, and how much of this is already captured in the valuation.Narrative Update • Jul 23
DCO: Missile Demand And Aero Recovery Will Offset Defense Budget Concerns
Analysts have lifted their fair value estimate for Ducommun stock from $173.80 to $181.00, reflecting updated views that incorporate recent price target increases across the Street, along with expectations for continued benefits from commercial aerospace strength and missile and munitions demand, tempered by potential budget pressure on parts of the legacy defense portfolio. Analyst Commentary Recent research on Ducommun points to a split view, with bullish analysts highlighting earnings execution and exposure to commercial aerospace and missiles, while more cautious analysts focus on valuation and defense budget risk.Narrative Update • Jul 09
DCO: Missile Demand And Aero Recovery Will Balance Defense Budget And Execution Risks
For Ducommun, the analyst fair value estimate has been revised to $173.80 from $164.00. Analysts point to updated price targets, expectations around missiles and munitions demand, and recent earnings and sector research as the key drivers of this change.New Narrative • Jul 02
Missile Demand And Engineered Content Shifts Will Expose Overvaluation Risks
Catalysts About Ducommun Ducommun supplies engineered components and assemblies for commercial aerospace, defense and related industrial applications. What are the underlying business or industry changes driving this perspective?Narrative Update • Jun 25
DCO: Q1 Execution And Aero Recovery Will Balance Restatement Governance Risks
Analysts have lifted their blended price target on Ducommun to approximately $164, reflecting updated models following the company’s Q1 earnings beat and improving commercial aerospace trends, alongside ongoing destocking concerns. Analyst Commentary on Ducommun Recent research on Ducommun points to a generally constructive tone, with price targets raised across multiple firms following the Q1 report and sector model updates, while still flagging a few key risks around end market trends and inventory normalization.Narrative Update • Jun 11
DCO: Q1 Execution And Defense Outlook Will Offset Restatement Governance Risks
Narrative Update on Ducommun Analysts have collectively raised their price targets on Ducommun into a range of about $150 to $187, citing Q1 earnings outperformance, better than expected commercial aerospace demand despite ongoing destocking, and updated aerospace and defense sector models that still indicate potential upside following recent selloffs. Analyst Commentary Recent research updates reflect a generally constructive stance on Ducommun, with higher price targets supported by Q1 execution and expectations around aerospace and defense demand, while still flagging some execution and end market risks.Narrative Update • May 28
DCO: Vision 2032 And Defense Backlog Will Offset Aerospace Destocking Risks
Analysts have lifted the Ducommun fair value estimate from $146.60 to $164.00, reflecting higher sector price targets after Q1 earnings beats and updated assumptions around revenue growth, profit margins, and future P/E multiples. Analyst Commentary Recent Street research on Ducommun highlights a broadly constructive tone after the latest Q1 earnings and earlier Q4 results, with several firms revisiting their models and price targets.Narrative Update • Apr 29
DCO: Defense Backlog And Vision 2032 Framework Will Steady Fair Outlook
Ducommun's updated fair value estimate has moved from $143.20 to $146.60 as analysts factor in a series of higher price targets tied to defense exposure, missile program visibility, and recent margin and backlog trends. Analyst Commentary Recent Street research on Ducommun centers on defense exposure, missile program visibility, and margin execution, which together are feeding into higher fair value estimates and revised price targets.Narrative Update • Apr 10
DCO: Defense Exposure And Vision 2032 Plan Will Shape Balanced Outlook
Analysts have made a slight trim to the Ducommun price target, lowering it by about $0.40. They are balancing recent target hikes tied to defense exposure, missile demand and margin plans with a modest reset following the latest Citi update.Narrative Update • Mar 27
DCO: Defense Exposure And Vision 2032 Plan Will Drive Long Term Upside
Analysts have nudged the Ducommun fair value estimate higher from $142.00 to $143.60. This reflects recent price target increases that are tied to expectations around defense exposure, missile related demand and updated margin ambitions discussed in recent research.Narrative Update • Mar 12
DCO: Defense Momentum And Vision 2032 Plan Will Shape Upside Through 2026
Narrative Update on Ducommun The analyst price target embedded in our fair value framework for Ducommun has been raised from $130 to $142. This change reflects analysts' higher published targets in the $136 to $155 range, supported by recent commentary around margin expansion, record Q4 revenue and EBITDA, defense program visibility, and the Vision 2032 plan focused on proprietary products and free cash flow.Narrative Update • Feb 26
DCO: Defense Agreements And Sector Momentum Will Shape Risk Balance Through 2026
The fair value estimate for Ducommun has been raised from $121.60 to $130.00 as analysts factor in higher Street price targets and improved visibility tied to long term defense agreements and updated aerospace and defense group estimates. Analyst Commentary Recent Street research on Ducommun focuses on higher price targets and updated expectations tied to the defense portfolio and broader aerospace and defense coverage.Narrative Update • Feb 11
DCO: Sector Momentum And Refined Assumptions Will Shape Risk Balance Through 2026
Narrative update on Ducommun The analyst price target for Ducommun has been lifted by $3.80 to $121.60. Analysts point to recent sector wide target increases from firms covering aerospace and defense as support for the higher fair value, as well as a slightly adjusted discount rate and future P/E assumptions.Narrative Update • Jan 28
DCO: Sector Momentum And M&A Plans Will Shape Risk Balance Through 2026
Analysts have increased their Ducommun fair value estimate from US$111.40 to US$117.80. This reflects updated assumptions on the discount rate, revenue growth, profit margins, and a higher future P/E multiple in the context of recent sector-wide price target increases.Narrative Update • Jan 13
DCO: Sector Momentum And Accounting Concerns Will Shape Risk Balance Through 2026
Analysts have lifted their price target on Ducommun to about US$111 from roughly US$106, reflecting updated assumptions on revenue growth, profit margins and a lower expected future P/E, alongside recent sector research indicating momentum in aerospace and defense through the first half of 2026. Analyst Commentary Bullish Takeaways Bullish analysts see the higher US$125 price target as reflecting confidence that Ducommun can support a richer valuation while still using a lower future P/E, given their updated revenue and margin assumptions.Narrative Update • Aug 08
Defense Modernization And Aerospace Recovery Will Reshape Markets
Ducommun's upward price target revision reflects notable improvements in both net profit margin and revenue growth forecasts, resulting in an increased consensus fair value from $99.25 to $106.25. What's in the News Ducommun dropped from the Russell 2000 Dynamic Index.Seeking Alpha • Apr 22
Duocommun: A Good Candidate For A Multi-Year Compounder
Summary Ducommun (DCO) is a promising investment in the aerospace and defense sector, with strong revenue growth potential despite economic challenges. The company’s diverse product offerings and strong financial position support organic growth and acquisitions, with significant contributions from military, space, and commercial aerospace. DCO's backlog and notable contracts with major players like RTX, Boeing, and Airbus indicate robust future revenue and earnings growth. The recent share price drop presents a compelling entry point, with a near-term price target of $75.50 and long-term growth potential. Read the full article on Seeking AlphaSeeking Alpha • Nov 22
Ducommun: Revenue Growth, Airbus Strength, And Vision 2027 Progress
Summary Ducommun reported 2.6% revenue growth, driven by military, space, and Airbus programs. Margins improved, with adjusted EBITDA margin expanding to 15.8% and adjusted EPS up 41%. Robust performance in Airbus A220 and A320 programs offset challenges from Boeing’s strike. Boeing’s recovery is expected to support growth in 2025-2026, especially for the 737 MAX and 787. Facility consolidations and operational streamlining are delivering initial savings, with projected annual savings of $11-13M. Defense backlog increased to $592M, driven by demand for TOW missiles and surveillance. Margin improvements align with DCO’s Vision 2027 goal of 18% adjusted EBITDA margin, supported by strong end markets, cost reductions, and improving aerospace production outlook. Read the full article on Seeking AlphaSeeking Alpha • Sep 19
Ducommun: Aerospace Growth And Strategic Restructuring Amid Boeing Challenges
Summary Ducommun continues to report revenue growth for 2Q24, driven by both commercial aerospace and military end markets. Additionally, margins expanded, driven by engineered products, pricing actions, and restructuring efforts. Despite ongoing challenges with Boeing and Spirit AeroSystems related to the 737 MAX, it achieved 12 consecutive quarters of revenue growth in commercial aerospace. Additionally, DCO's fuselage skin project for the 737 MAX, expected to start production by late 2024, is expected to bolster the company's aerospace business outlook. While the Boeing strike presents near-term headwinds, DCO's strategic restructuring and cost-saving initiatives, combined with improving production rates, are expected to boost margins and profitability in the long term. Read the full article on Seeking Alpha
New Narrative • Sep 16
Strategic Moves And Aerospace Focus Set To Skyrocket Efficiency And Earnings
Consolidating facilities and increasing engineered products and aftermarket content are key strategies to boost operational efficiency and net margins.Seeking Alpha • Jul 16
Ducommun: Robust Air Travel Demand And Defence Backlog
Summary DCO's historical financial results have shown consistent top-line growth. However, margins were contracting modestly. For 1Q24, net revenue continued to grow. Additionally, its margins expanded when compared to previous period. DCO's defence backlog is growing, which is a sign that its defence business is growing. Additionally, DCO raised the run rate of the SPY-6 and other defence programmes. Currently, air travel demand is strong, and ICAO forecasts it to continue growing. The robust air travel demand is expected to bolster the DCO outlook. Read the full article on Seeking AlphaSeeking Alpha • Apr 21
Ducommun: Management Expects Margin Expansion And Revenue Growth
Summary Although Ducommun's commercial aerospace business faced substantial headwinds given the beginning of the pandemic, demand from the market has continued to recover in recent years. On April 16, 2024, Ducommun's board rejected an unsolicited, non-binding indication of interest from Albion River LLC offering $60 in cash per share. Ducommun's board feels the offer doesn't fully reflect the company's Vision 2027 plan where the company sees meaningful adjusted EBITDA margin expansion and continued revenue growth. I rate Ducommun a 'Buy' and I would own it in a diversified portfolio given the company's growth potential and relatively attractive valuation with forward EV/EBITDA ratio of 9.18. Read the full article on Seeking AlphaAnalysis Article • Apr 17
We Think Shareholders May Want To Consider A Review Of Ducommun Incorporated's (NYSE:DCO) CEO Compensation Package
Key Insights Ducommun to hold its Annual General Meeting on 24th of April Salary of US$959.7k is part of CEO Steve...Analysis Article • Feb 18
Ducommun Incorporated Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Shareholders might have noticed that Ducommun Incorporated ( NYSE:DCO ) filed its annual result this time last week...Seeking Alpha • Feb 06
Ducommun Stock Is Still A Buy On End Market Growth
Summary Ducommun Incorporated has gained 12.9% since September 2023, outperforming the S&P 500. The company operates in the aerospace industry, serving major companies such as Boeing and Airbus. Ducommun has significant growth drivers, including exposure to commercial airplane programs and increased defense budgets. Read the full article on Seeking AlphaShareholder Returns
| DCO | US Aerospace & Defense | US Market | |
|---|---|---|---|
| 7D | 2.2% | -1.0% | -0.1% |
| 1Y | 78.4% | 4.0% | 11.9% |
Return vs Industry: DCO exceeded the US Aerospace & Defense industry which returned 4% over the past year.
Return vs Market: DCO exceeded the US Market which returned 11.9% over the past year.
Price Volatility
| DCO volatility | |
|---|---|
| DCO Average Weekly Movement | 6.4% |
| Aerospace & Defense Industry Average Movement | 8.5% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: DCO has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: DCO's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1849 | 2,130 | Steve Oswald | www.ducommun.com |
Ducommun Incorporated provides engineering and manufacturing services for products and applications used in the aerospace and defense, industrial, medical, and other industries in the United States. It operates through two segments, Electronic Systems and Structural Systems. The Electronic Systems segment provides cable assemblies and interconnect systems; printed circuit board assemblies; electronic, electromechanical, and mechanical components and assemblies, as well as lightning diversion systems; and radar enclosures, aircraft avionics racks, shipboard communications and control enclosures, wire harnesses, interconnect systems, lightning diversion strips, surge suppressors, conformal shields, and other assemblies.
Ducommun Incorporated Fundamentals Summary
| DCO fundamental statistics | |
|---|---|
| Market cap | US$2.51b |
| Earnings (TTM) | -US$21.19m |
| Revenue (TTM) | US$865.07m |
2.9x
P/S Ratio-119.8x
P/E RatioIs DCO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DCO income statement (TTM) | |
|---|---|
| Revenue | US$865.07m |
| Cost of Revenue | US$627.75m |
| Gross Profit | US$237.32m |
| Other Expenses | US$258.52m |
| Earnings | -US$21.19m |
Last Reported Earnings
Jul 04, 2026
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.40 |
| Gross Margin | 27.43% |
| Net Profit Margin | -2.45% |
| Debt/Equity Ratio | 40.0% |
How did DCO perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/09/21 21:55 |
| End of Day Share Price | 2026/09/21 00:00 |
| Earnings | 2026/07/04 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ducommun Incorporated is covered by 13 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Crawford | B. Riley Securities, Inc. |
| Kenneth Herbert | Canaccord Genuity |
| John Godyn | Citigroup Inc |